Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![Lycanbull Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1825866616254480384.png) Lycanbull [@Lycanbull](/creator/twitter/Lycanbull) on x 4980 followers
Created: 2025-05-13 13:25:20 UTC

$SRPT Sarepta Therapeutics Announces Approval in Japan of ELEVIDYS, a Gene Therapy to Treat Duchenne Muscular Dystrophy


![](https://pbs.twimg.com/card_img/1920582444496871424/leOkGi1s?format=png&name=600x314)

XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1922282011948994734/c:line.svg)

**Related Topics**
[japan](/topic/japan)
[sarepta therapeutics](/topic/sarepta-therapeutics)
[$srpt](/topic/$srpt)
[sarepta therapeutics inc](/topic/sarepta-therapeutics-inc)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/Lycanbull/status/1922282011948994734)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Lycanbull Avatar Lycanbull @Lycanbull on x 4980 followers Created: 2025-05-13 13:25:20 UTC

$SRPT Sarepta Therapeutics Announces Approval in Japan of ELEVIDYS, a Gene Therapy to Treat Duchenne Muscular Dystrophy

XXXXX engagements

Engagements Line Chart

Related Topics japan sarepta therapeutics $srpt sarepta therapeutics inc stocks healthcare

Post Link

post/tweet::1922282011948994734
/post/tweet::1922282011948994734